Coronavirus vaccine update: Bharat Biotech's Covaxin to start human trial
- 4 years ago
The total number of coronavirus cases across the world has crossed the 10-million mark and the death toll has gone past 500,000.
There currently are over 100 vaccines at various stages of development worldwide, including in India, Britain, China, the US, Russia and Israel.
Dr Soumya Swaminathan, the chief scientist at WHO, said nearly 2 billion doses of the Covid-19 vaccine would be ready by the end of next year. But who would be the first to get a Covid-19 vaccine? Probably people in the country where the first effective vaccine is developed.
Thus, there's pressure from governments on pharmaceutical companies and scientists to come up with a vaccine as soon as possible. Last week, WHO said UK-based AstraZeneca was leading the vaccine race while US-based pharmaceutical major Moderna was not far behind.
Several drugs, however, have shown encouraging results. While a definite treatment for coronavirus is nowhere in sight, drugs like dexamethasone and remdesivir are being used
There currently are over 100 vaccines at various stages of development worldwide, including in India, Britain, China, the US, Russia and Israel.
Dr Soumya Swaminathan, the chief scientist at WHO, said nearly 2 billion doses of the Covid-19 vaccine would be ready by the end of next year. But who would be the first to get a Covid-19 vaccine? Probably people in the country where the first effective vaccine is developed.
Thus, there's pressure from governments on pharmaceutical companies and scientists to come up with a vaccine as soon as possible. Last week, WHO said UK-based AstraZeneca was leading the vaccine race while US-based pharmaceutical major Moderna was not far behind.
Several drugs, however, have shown encouraging results. While a definite treatment for coronavirus is nowhere in sight, drugs like dexamethasone and remdesivir are being used